We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
TESTIS CANCER - Interactive survival scatter ploti
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
: Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A 5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A 5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as median FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average FPKM
665.2
Number of samples
134
Samples
Sample
Description
FPKM
TCGA-YU-A90S-01A
26 years, male, white, stage:ia, alive, 971 days
6347.8
TCGA-VF-A8AB-01A
31 years, male, black or african american, stage:ia, alive, 760 days
5845.1
TCGA-ZM-AA0H-01A
50 years, male, white, stage:is, alive, 1736 days
2952.9
TCGA-XY-A89B-01A
35 years, male, white, stage:ia, alive, 471 days
2810.9
TCGA-2G-AAHN-01A
32 years, male, white, stage:i, alive, 6445 days
2553.4
TCGA-2G-AAHA-01A
48 years, male, white, stage:ib, alive, 3349 days
2533.0
TCGA-4K-AA1H-01A
26 years, male, white, stage:ia, alive, 518 days
2216.8
TCGA-2G-AAHC-01A
33 years, male, white, stage:is, alive, 5539 days
2016.5
TCGA-XE-AAOB-01A
27 years, male, white, stage:is, dead, 513 days
1977.5
TCGA-ZM-AA0D-01A
34 years, male, white, stage:ia, alive, 848 days
1796.4
TCGA-2G-AAG9-01A
25 years, male, white, stage:iiib, alive, 2234 days
1771.7
TCGA-4K-AA1I-01A
26 years, male, white, stage:ia, alive, 3 days
1535.4
TCGA-ZM-AA0F-01A
35 years, male, white, stage:ia, alive, 681 days
1510.9
TCGA-XE-A8H4-01A
23 years, male, white, stage:ia, alive, 559 days
1465.5
TCGA-2G-AAEW-01A
31 years, male, white, stage:is, dead, 618 days
1388.1
TCGA-2G-AAFG-01A
30 years, male, white, stage:is, alive, 6183 days
1238.8
TCGA-2G-AAHT-01A
32 years, male, white, stage:is, alive, 542 days
1164.0
TCGA-VF-A8AE-01A
39 years, male, white, stage:ia, alive, 727 days
1081.2
TCGA-2G-AAGZ-01A
27 years, male, white, stage:iiia, alive, 5233 days
987.7
TCGA-X3-A8G4-01A
33 years, male, white, stage:is, alive, 856 days
985.6
TCGA-2X-A9D5-01A
49 years, male, white, stage:i, alive, 435 days
985.2
TCGA-2G-AAF6-01A
28 years, male, white, stage:is, alive, 3491 days
953.8
TCGA-YU-A912-01A
34 years, male, black or african american, stage:iiic, alive, 866 days
899.8
TCGA-VF-A8AD-01A
36 years, male, white, stage:ib, alive, 1006 days
895.8
TCGA-2G-AAFH-01A
38 years, male, white, stage:iib, alive, 1375 days
893.4
TCGA-WZ-A8D5-01A
38 years, male, white, alive, 774 days
867.8
TCGA-2G-AAGP-01A
33 years, male, white, stage:iia, alive, 4018 days
827.4
TCGA-2G-AAFE-01A
37 years, male, white, stage:iia, alive, 4702 days
826.1
TCGA-XE-AAOD-01A
39 years, male, white, stage:ib, alive, 2058 days
825.8
TCGA-2G-AAFY-01A
24 years, male, white, stage:iia, alive, 1099 days
797.5
TCGA-VF-A8A9-01A
31 years, male, white, stage:ia, alive, 1119 days
796.3
TCGA-WZ-A7V4-01A
28 years, male, white, stage:i, alive, 894 days
795.9
TCGA-2G-AAH0-01A
30 years, male, white, stage:is, alive, 5477 days
763.1
TCGA-2G-AAF1-01A
28 years, male, asian, stage:is, alive, 1403 days
752.6
TCGA-2X-A9D6-01A
42 years, male, white, stage:i, alive, 607 days
751.6
TCGA-WZ-A7V5-01A
27 years, male, white, stage:i, alive, 1061 days
742.0
TCGA-ZM-AA05-01A
36 years, male, white, stage:iic, alive, 1126 days
740.8
TCGA-ZM-AA0E-01A
39 years, male, white, stage:ia, alive, 811 days
724.4
TCGA-XE-AANV-01A
52 years, male, stage:ib, alive, 1701 days
719.7
TCGA-XE-AAOF-01A
50 years, male, asian, stage:ia, alive, 1268 days
697.0
TCGA-VF-A8AA-01A
51 years, male, white, stage:i, alive, 1146 days
687.3
TCGA-XE-A9SE-01A
35 years, male, white, stage:ia, alive, 708 days
675.6
TCGA-SB-A6J6-01A
22 years, male, white, stage:ia, alive, 413 days
669.4
TCGA-W4-A7U3-01A
26 years, male, white, alive, 149 days
649.7
TCGA-4K-AAAL-01A
31 years, male, white, stage:is, alive, 483 days
633.3
TCGA-VF-A8AC-01A
29 years, male, white, stage:ia, alive, 1083 days
581.7
TCGA-2G-AAHL-01A
26 years, male, white, stage:i, alive, 7081 days
576.9
TCGA-XY-A9T9-01A
37 years, male, white, stage:is, alive, 281 days
575.3
TCGA-2G-AAFL-01A
35 years, male, white, stage:ib, alive, 750 days
572.7
TCGA-2G-AAH4-01A
34 years, male, white, stage:ii, alive, 6210 days
550.7
TCGA-YU-AA61-01A
29 years, male, white, stage:is, alive, 864 days
547.3
TCGA-2G-AAFO-01A
33 years, male, white, stage:iia, alive, 685 days
546.9
TCGA-2G-AAF4-01A
30 years, male, white, stage:i, alive, 2315 days
538.9
TCGA-XE-AANR-01A
24 years, male, white, stage:i, alive, 14 days
537.1
TCGA-YU-A90P-01A
25 years, male, white, stage:ia, alive, 2069 days
536.6
TCGA-XE-AANJ-01A
39 years, male, white, stage:is, alive, 2007 days
513.6
TCGA-2G-AAGJ-01A
28 years, male, black or african american, stage:ia, alive, 2938 days
512.3
TCGA-2G-AAH3-01A
20 years, male, white, stage:i, alive, 1822 days
505.0
TCGA-ZM-AA0B-01A
32 years, male, white, stage:ia, alive, 838 days
494.5
TCGA-2G-AAFM-01A
31 years, male, white, stage:iia, alive, 503 days
481.1
TCGA-2G-AAGG-01A
20 years, male, white, stage:iiic, alive, 2611 days
471.7
TCGA-YU-A90Y-01A
23 years, male, black or african american, stage:iiic, dead, 17 days
456.2
TCGA-XE-AAO4-01A
40 years, male, white, stage:ia, alive, 367 days
444.8
TCGA-2G-AAG5-01A
36 years, male, white, stage:is, alive, 2299 days
439.7
TCGA-2G-AAGI-01A
33 years, male, white, stage:is, alive, 3137 days
438.7
TCGA-2G-AAEX-01A
38 years, male, white, stage:is, alive, 1259 days
418.3
TCGA-SN-A84X-01A
21 years, male, white, stage:is, alive, 312 days
403.6
TCGA-2G-AAGT-01A
30 years, male, white, stage:is, alive, 4406 days
402.6
TCGA-2G-AAG8-01A
21 years, male, white, stage:ib, alive, 2289 days
402.5
TCGA-2G-AAG6-01A
24 years, male, white, stage:is, alive, 2231 days
389.4
TCGA-2G-AAKH-01A
19 years, male, white, stage:ii, alive, 6862 days
376.7
TCGA-2G-AAG0-01A
23 years, male, white, stage:is, alive, 1529 days
374.0
TCGA-2G-AAGC-01A
28 years, male, white, stage:is, alive, 2585 days
371.5
TCGA-ZM-AA0N-01A
44 years, male, white, stage:ib, alive, 634 days
370.3
TCGA-XE-AAO6-01A
47 years, male, white, stage:ia, alive, 240 days
367.6
TCGA-2G-AAF8-01A
33 years, male, white, stage:ia, alive, 3911 days
364.8
TCGA-2G-AAKG-01A
22 years, male, white, stage:i, alive, 6598 days
360.3
TCGA-2G-AAFV-01A
31 years, male, white, stage:is, alive, 1389 days
351.1
TCGA-4K-AA1G-01A
34 years, male, white, stage:is, alive, 436 days
350.9
TCGA-XE-A8H5-01A
29 years, male, stage:is, alive, 1217 days
342.8
TCGA-2G-AAGK-01A
20 years, male, white, stage:is, alive, 3621 days
331.4
TCGA-2G-AAH8-01A
45 years, male, white, stage:iiic, alive, 2248 days
326.3
TCGA-2G-AAH2-01A
20 years, male, white, stage:is, alive, 6060 days
324.8
TCGA-2G-AAG3-01A
53 years, male, white, stage:is, alive, 1593 days
323.5
TCGA-XE-AAOC-01A
31 years, male, white, stage:ia, alive, 270 days
323.5
TCGA-2G-AAGY-01A
28 years, male, white, stage:is, alive, 5329 days
309.1
TCGA-YU-A90W-01A
45 years, male, white, stage:ia, alive, 1113 days
297.4
TCGA-WZ-A7V3-01A
20 years, male, white, stage:i, alive, 753 days
290.3
TCGA-S6-A8JY-01A
27 years, male, white, stage:is, alive, 278 days
273.7
TCGA-YU-AA4L-01A
27 years, male, black or african american, stage:iiic, alive, 1573 days
268.7
TCGA-2G-AAKL-01A
26 years, male, white, stage:ii, alive, 7023 days
267.8
TCGA-W4-A7U4-01A
23 years, male, white, alive, 738 days
267.2
TCGA-W4-A7U2-01A
26 years, male, white, alive, 1263 days
262.7
TCGA-2G-AAGE-01A
21 years, male, white, stage:is, alive, 2478 days
233.7
TCGA-2G-AAKM-01A
14 years, male, white, stage:ii, dead, 6972 days
232.6
TCGA-XE-A8H1-01A
24 years, male, white, stage:is, alive, 209 days
228.2
TCGA-2G-AAGN-01A
41 years, male, white, stage:iiib, alive, 3656 days
227.0
TCGA-2G-AAHG-01A
25 years, male, white, stage:i, alive, 1819 days
224.3
TCGA-XE-AANI-01A
37 years, male, white, stage:is, alive, 1041 days
218.3
TCGA-SN-A6IS-01A
26 years, male, white, stage:is, alive, 496 days
215.1
TCGA-S6-A8JW-01A
37 years, male, white, stage:is, alive, 698 days
212.3
TCGA-XY-A8S2-01A
67 years, male, white, stage:i, alive, 672 days
203.3
TCGA-2G-AAKD-01A
18 years, male, white, stage:iii, alive, 6340 days
201.0
TCGA-ZM-AA06-01A
45 years, male, white, stage:ib, alive, 1498 days
192.7
TCGA-2G-AAGM-01A
51 years, male, white, stage:is, alive, 3891 days
181.8
TCGA-XE-AAO3-01A
33 years, male, asian, stage:i, alive, 2857 days
173.0
TCGA-2G-AAFI-01A
41 years, male, white, stage:ib, alive, 675 days
166.5
TCGA-SN-A84W-01A
30 years, male, white, stage:is, alive, 293 days
158.7
TCGA-2G-AAFN-01A
26 years, male, white, stage:iiib, alive, 773 days
144.1
TCGA-2G-AAL7-01A
32 years, male, white, stage:is, alive, 3991 days
141.4
TCGA-2G-AAGF-01A
28 years, male, white, stage:is, alive, 2734 days
135.7
TCGA-2G-AAG7-01A
33 years, male, white, stage:is, alive, 2475 days
131.1
TCGA-2G-AAFZ-01A
32 years, male, white, stage:iii, alive, 1353 days
130.4
TCGA-SB-A76C-01A
38 years, male, white, alive, 42 days
128.3
TCGA-SN-A84Y-01A
18 years, male, white, stage:is, alive, 524 days
120.6
TCGA-2G-AALP-01A
43 years, male, white, stage:iiib, alive, 2645 days
120.5
TCGA-2G-AAGX-01A
22 years, male, white, stage:ia, alive, 5514 days
118.0
TCGA-2G-AAFJ-01A
23 years, male, asian, alive, 792 days
110.9
TCGA-XY-A8S3-01B
24 years, male, white, stage:is, alive, 843 days
110.5
TCGA-2G-AAGV-01A
23 years, male, white, alive, 4527 days
107.0
TCGA-SO-A8JP-01A
29 years, male, white, stage:i, alive, 540 days
96.1
TCGA-2G-AAGA-01A
38 years, male, white, stage:iia, alive, 2439 days
93.2
TCGA-YU-A94D-01A
28 years, male, stage:iiib, alive, 2167 days
92.5
TCGA-2G-AAGS-01A
39 years, male, white, stage:iiib, alive, 4816 days
89.0
TCGA-2G-AAGO-01A
41 years, male, white, stage:is, alive, 4026 days
86.4
TCGA-YU-A94I-01A
66 years, male, stage:ia, alive, 536 days
75.7
TCGA-2G-AAL5-01A
31 years, male, white, stage:i, alive, 7437 days
74.1
TCGA-YU-A90Q-01A
21 years, male, stage:ib, alive, 1964 days
71.8
TCGA-VF-A8A8-01A
18 years, male, white, stage:ia, alive, 1131 days
69.1
TCGA-2G-AAHP-01A
31 years, male, white, stage:is, alive, 5667 days
66.2
TCGA-XE-AAOJ-01A
24 years, male, white, stage:is, alive, 1550 days
61.8
TCGA-S6-A8JX-01A
27 years, male, white, stage:ib, alive, 552 days
54.7
TCGA-XE-AAOL-01A
38 years, male, black or african american, stage:i, alive, 13 days
48.2
TCGA-2G-AAGW-01A
38 years, male, white, stage:is, alive, 4899 days
12.1
Show allShow less
TESTIS CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high. This score is based on the staining intensity and fraction of stained cells.